pirfenidone has been researched along with Liver Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Armendariz-Borunda, J; Galicia-Moreno, M; Lucano-Landeros, S; Miranda-Roblero, HO; Monroy-Ramirez, HC; Sandoval-Rodriguez, A; Santos, A; Silva-Gomez, JA | 1 |
| Fan, Z; Li, Z; Liang, J; Liu, Y; Lv, Y; Shen, S; Shen, Y; Wang, L; Xu, G; Zhang, F; Zhang, S; Zhang, Y; Zhao, J; Zhou, S; Zhu, Y; Zou, X | 1 |
| Cai, M; Chen, J; Chen, Y; Guo, Y; Huang, J; Huang, W; Lai, M; Liang, L; Lin, L; Liu, M; Xie, L; Zhang, X; Zhang, Y; Zhu, K | 1 |
| Huang, Z; Jiang, TP; Shen, YP; Zhang, S; Zhao, AS; Zhou, S; Zou, WJ | 1 |
| Bernal, JA; Blanco, Ó; Bravo, J; Caballero, A; Caballero, B; Cubero, FJ; Feixas, F; González-Terán, B; Hernández-Cosido, L; Leiva-Vega, L; León, M; López, JA; Malumbres, M; Manieri, E; Marcos, M; Matesanz, N; Miranda-Saavedra, D; Mischo, H; Montalvo-Romeral, V; Mora, A; Nevzorova, YA; Osuna, S; Pintor-Chocano, A; Roche-Molina, M; Rodríguez, E; Romero-Becerra, R; Ruiz-Cabello, J; Sabio, G; Santamans, AM; Tomás-Loba, A; Torres, JL; Trakala, M; Vázquez, J | 1 |
| Chen, C; Jing, L; Liu, Y; Sun, X; Wang, H; Wen, G; Xu, Y; Yao, X; Zhang, Q; Zhao, L | 1 |
| Araki, K; Hirai, K; Hoshino, K; Igarashi, T; Ishii, N; Kubo, N; Kuwano, H; Saitoh, F; Shirabe, K; Tsukagoshi, M; Watanabe, A; Yamanaka, T | 1 |
1 review(s) available for pirfenidone and Liver Neoplasms
| Article | Year |
|---|---|
Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Disease Progression; Hepatectomy; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Male; Mucin-1; Perioperative Care; Postoperative Complications; Pyridones; Respiration Disorders; Tomography, X-Ray Computed | 2017 |
6 other study(ies) available for pirfenidone and Liver Neoplasms
| Article | Year |
|---|---|
Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio.
Topics: Animals; Anti-Inflammatory Agents; Carcinogenesis; Carcinoma, Hepatocellular; Fibrosis; Inflammation; Liver Neoplasms; Male; NF-kappa B; NF-kappa B p50 Subunit; Phosphorylation; PPAR gamma; Pyridones; Rats; Rats, Inbred F344; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta1 | 2021 |
Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Exosomes; Humans; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms | 2022 |
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Hyaluronoglucosaminidase; Liver Neoplasms; Lung Neoplasms; Signal Transduction; Sorafenib; Tumor Microenvironment | 2023 |
Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Topics: Apoptosis; beta Catenin; Carcinoma, Hepatocellular; Cell Count; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Pyridones; Signal Transduction; Wnt Signaling Pathway | 2017 |
p38γ is essential for cell cycle progression and liver tumorigenesis.
Topics: Aged; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinases; Female; Hepatocytes; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase 12; Phosphorylation; Pyridones; Retinoblastoma Protein; Sequence Homology; Substrate Specificity | 2019 |
Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
Topics: Antineoplastic Agents, Phytogenic; Chemokine CCL2; Colorectal Neoplasms; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Macrophages; Neoplasm Metastasis; Neoplasms, Experimental; Pyridones; Pyrrolidinones; Receptors, CCR2 | 2019 |